This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Pharmacokinetics and Clinical Implications of Semaglutide: A New Glucagon-Like Peptide (GLP)-1 Receptor Agonist.
Clinical pharmacokinetics, 57(12), 1529-1538
Citation
Hall, Sylvie; Isaacs, Diana; Clements, Jennifer N. (2018). Pharmacokinetics and Clinical Implications of Semaglutide: A New Glucagon-Like Peptide (GLP)-1 Receptor Agonist.. Clinical pharmacokinetics, 57(12), 1529-1538. https://doi.org/10.1007/s40262-018-0668-z